Drug · DIN 02325233
BICALUTAMIDE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 20, 2014; first marketed June 22, 2009.
- Drug Identification Number (DIN)
- 02325233
- Company (DIN owner)
- Sorres Pharma IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bicalutamide L02BB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BICALUTAMIDE | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 9, 2010: NOC 11238Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- May 12, 2009: NOC 10205Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named BICALUTAMIDE
- DIN 02519178 · Marketed
- DIN 02382423 · Cancelled Post Market